Optimer Pharmaceuticals Reports Preliminary 2012 Gross Product Sales of $74.4 Million

4th Quarter 2012 Gross DIFICID® Sales of $21.3 Million, Up 74.7% Over 4th Quarter 2011 and 14.4% Above the 3rd Quarter of 2012

Optimer Launches DIFICID Co-Pay Assistance Program and Announces Price Increase

Jan 07, 2013, 08:00 ET from Optimer Pharmaceuticals, Inc.

$countyNameToPathMap.put("sp